BioMarin Pharmaceutical Inc. (BMRN) PT Lowered to $100 at Credit Suisse

October 28, 2021 5:49 AM EDT
Get Alerts BMRN Hot Sheet
Price: $84.41 +1.76%

Rating Summary:
    23 Buy, 9 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 25 | Down: 13 | New: 72
Trade Now! 
Join SI Premium – FREE
Credit Suisse analyst Martin Auster lowered the price target on BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) to $100.00 (from $102.00) while maintaining a Outperform rating.

You May Also Be Interested In





Related Categories

Analyst PT Change